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Orthogonal monoterpenoid biosynthesis in yeast
constructed on an isomeric substrate
Codruta Ignea 1,5, Morten H. Raadam 1, Mohammed S. Motawia 1, Antonios M. Makris2,
Claudia E. Vickers 3,4 & Sotirios C. Kampranis1
Synthetic biology efforts for the production of valuable chemicals are frequently hindered by
the structure and regulation of the native metabolic pathways of the chassis. This is parti-
cularly evident in the case of monoterpenoid production in Saccharomyces cerevisiae, where
the canonical terpene precursor geranyl diphosphate is tightly coupled to the biosynthesis of
isoprenoid compounds essential for yeast viability. Here, we establish a synthetic orthogonal
monoterpenoid pathway based on an alternative precursor, neryl diphosphate. We identify
structural determinants of isomeric substrate selectivity in monoterpene synthases and
engineer ﬁve different enzymes to accept the alternative substrate with improved efﬁciency
and speciﬁcity. We combine the engineered enzymes with dynamic regulation of metabolic
ﬂux to harness the potential of the orthogonal substrate and improve the production of
industrially-relevant monoterpenes by several-fold compared to the canonical pathway. This
approach highlights the introduction of synthetic metabolism as an effective strategy for
high-value compound production.
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Synthetic biology approaches for the production of valuablechemicals intervene in the native metabolic pathways of thechassis to balance synthesis of the desired chemical with the
production of biomass. However, the structure and regulation of
native metabolism has been optimized through evolution to suit
the speciﬁc needs of the host organism, frequently making it
particularly challenging to redirect metabolic ﬂuxes toward the
heterologous pathway introduced to synthesize the desirable
product. A solution to overcome this obstacle would be to make
the heterologous pathway less connected to the chassis’ native
metabolism. Ideally, a heterologous pathway must be orthogonal
to the host pathways. The concept of orthogonality describes the
ability of a system component to be varied without affecting the
performance of other components of the same system (e.g., an
orthogonal ribosome speciﬁcally translates an orthogonal mRNA
that is not a substrate for cellular ribosomes)1. Although, when
used broadly, the term “orthogonal” denotes independence, when
applied to biosynthetic pathways, it denotes minimum depen-
dence2. This is because the orthogonal pathway still requires
precursor inﬂux from the chassis. Thus, for a pathway to be
orthogonal, it must have only a single branch point from basic
metabolism3. Establishing an orthogonal route is advantageous
for improved pathway control and performance. The unique
branching point can be exploited to create a metabolic valve to
redirect ﬂuxes to the orthogonal route and enable dynamic reg-
ulation in response to the metabolic status or growth phase4–9.
A characteristic case, where the establishment of an orthogonal
metabolic pathway could be beneﬁcial, is the synthesis of
monoterpenoids in Saccharomyces cerevisiae. Monoterpenoids are
widely used as ﬂavors, antibacterials, and insecticides10,11, and
recently, their applications have expanded to include high-density
fuels, renewable polymers, and green plastics12. However,
extraction of monoterpenoids from natural sources cannot meet
the increasing demand, prompting efforts for their biotechnolo-
gical production in microorganisms13–17. Monoterpene scaffolds
are synthesized by the conversion of the canonical 10-carbon
terpene precursor geranyl diphosphate (GPP) by monoterpene
synthases, which catalyze the rearrangement of the substrate to
generate a plethora of structures18 (Fig. 1). GPP itself is formed
by the fusion of two C5 units, dimethylallyl diphosphate
(DMAPP) and isopentenyl diphosphate (IPP). Further addition
of IPP to GPP generates the 15-carbon farnesyl diphosphate
(FPP), a precursor of the sesquiterpenes (C15), diterpenes (C20),
polyprenols, ubiquinone, and sterols.
The yeast S. cerevisiae is an attractive host for terpene bio-
production, due to its robustness, applicability to industrial bio-
processes, and the possibility for terpene scaffold decoration by
the functional expression of cytochrome P450 enzymes. Meta-
bolic engineering efforts in yeast for the production of FPP-
derived compounds, such as the sesquiterpenes artemisinin and
farnesene, have achieved industrial-scale levels19–22. However,
production of GPP-derived compounds has so far been con-
siderably less efﬁcient14,23,24. One of the factors contributing to
this lower efﬁciency may be the structure of the isoprenoid bio-
synthesis pathway in yeast, which is optimized for the production
of FPP-derived molecules that are essential for growth and via-
bility. A key feature of the pathway that highlights this metabolic
optimization is the sequential nature of FPP synthesis by the
native yeast prenyltransferase, Erg20p. Erg20p is a bifunctional
enzyme that catalyzes two successive steps of the pathway; initi-
ally, it condenses DMAPP and IPP to form GPP, and subse-
quently it catalyzes the condensation of GPP with one more IPP
molecule to generate FPP25 (Fig. 1). This facilitates the metabolic
economy of the cell26, as yeast does not naturally produce other
GPP-derived compounds. However, the sequential reaction cat-
alyzed by Erg20p appears to limit the GPP pool, hindering
monoterpenoid production14. Overexpression of a GPP synthase
to increase GPP availability resulted in only a moderate mono-
terpene increase, because the increased GPP ﬂux was efﬁciently
channeled by the endogenous Erg20p to produce sterols and
other essential isoprenoids14. Further efforts, in which Erg20p
was engineered to be inefﬁcient only in the FPP-synthesizing step,
increased the GPP pool without abolishing sterol synthesis14.
However, despite additional improvements through N-degron-
dependent protein degradation of the native Erg20p to minimize
competition with the introduced monoterpene synthase23, the
obtained monoterpene titers were orders of magnitude lower than
the titers of sesquiterpene production by other engineered yeast
platforms21,22,24,27. These observations suggest that there is still
considerable potential for improving the monoterpene bio-
synthesis in yeast.
To overcome limitations in monoterpene production that may
be imposed by the structure and regulation of the yeast native
metabolism, we set out to establish an orthogonal pathway. To
achieve orthogonality, the new pathway must have only one
branching point from yeast metabolism. To meet this require-
ment, the synthetic pathway must not involve GPP because
Erg20p connects GPP back to basic yeast metabolism via FPP
(Fig. 1). This requirement creates a considerable challenge, as
GPP is the precursor of monoterpenes. Thus, we examined the
possibility of using alternative precursors for monoterpene bio-
synthesis. Although it has been shown that GPP is the canonical
substrate of monoterpene synthases18, recent studies in different
tomato species have revealed the existence of a small group of
enzymes that deviate from this rule and preferentially convert the
cis-isomer of GPP, neryl diphosphate (NPP), to a limited number
of monoterpene hydrocarbons28–30. A dedicated cis-pre-
nyltransferase, neryl diphosphate synthase (SlNPPS1), was found
to generate the required NPP substrate by condensing DMAPP
and IPP in the cis-conﬁguration28 (Fig. 1). NPP and NPP-derived
monoterpene biosynthesis has only been observed in these few
plant species and is entirely absent in yeast.
Here, we use NPP as an alternative substrate to establish an
orthogonal pathway for monoterpene scaffold production. We
identify a single residue dictating isomeric substrate selectivity in
a monoterpene synthase and engineer canonical terpene syn-
thases to speciﬁcally accept the alternative substrate. As a result,
we establish a complete synthetic pathway that extends up to the
step of monoterpene oxidation and achieve marked improve-
ments in the production of several industrially important
monoterpenes.
Results
Justifying the construction of an orthogonal monoterpene
pathway. To justify the need for constructing an orthogonal
pathway, we ﬁrst conﬁrmed that the low titers of monoterpene
observed in previous efforts14,23 were not due to product toxicity,
and that additional factors, such as pathway structure, may play
an important role. We evaluated the growth of yeast cells engi-
neered to provide high levels of isoprenoid precursors (strain
AM94; Supplementary Table 1) under conditions that recapitu-
late production of speciﬁc titers of monoterpenes. In agreement
with previous studies31,32, yeast cells grew equally well when
supplemented with increasing monoterpene concentrations up to
500 mg L−1 (Supplementary Fig. 1), which was more than seven
times higher than the current best-production titers23. Subse-
quently, we introduced the Citrus limon limonene synthase
(ClLimS)33 into strain AM94 and conﬁrmed that limonene pro-
ductivity was not reduced, even when the culture was supple-
mented with a limonene concentration that was tenfold higher
than the titer produced by the strain (Supplementary Fig. 2).
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To further corroborate previous evidence suggesting that the
sequential reaction of Erg20p may be a contributing factor to low
monoterpene productivity14, we supplemented the cell extract of
ClLimS-expressing AM94 cells with isoprenoid precursors and
measured the formation of limonene. Addition of GPP, in the
presence of IPP and DMAPP, resulted in the production of low
amounts of limonene and a signiﬁcant larger amount of FPP
(Supplementary Fig. 3). This suggested that most of the GPP
precursor was used by Erg20p to synthesize FPP, and only a small
amount of the GPP added was converted to limonene by ClLimS
(Supplementary Fig. 3). Further experiments using 13C-GPP
conﬁrmed that <10% of the 13C-GPP was converted to limonene
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Fig. 1 Engineering an orthogonal monoterpene biosynthetic pathway in yeast. The native yeast isoprenoid biosynthesis includes pathways responsible for
the synthesis of sterols, dolichols, ubiquinone, as well as protein prenylation. Production of monoterpenoids in yeast has so far been based on utilizing the
GPP synthesized as an intermediate in primary isoprenoid metabolism. This GPP-based non-orthogonal pathway (shown in gray) connects back to primary
metabolism through the Erg20p-catalyzed conversion of GPP to FPP. Expression of SlNPPS1 in yeast cells enables the synthesis of the cis-isomer of GPP,
NPP, which cannot be converted to FPP and links back to the biosynthesis of yeast isoprenoids. NPP can be utilized by engineered monoterpene synthases
to produce different monoterpenes. The NPP-based pathway, depicted in green, is orthogonal to the yeast metabolism, because it branches out from
the main pathway only at one point, following the synthesis of IPP and DMAPP. This branch point creates a metabolic valve, depicted here using the
engineering symbol for a three-point valve, which can be regulated to direct ﬂuxes to the desired products. This valve can be controlled dynamically to
regulate ﬂuxes between the two branches. We installed dynamic regulation by introducing the ergosterol-repressed promoter of the ERG1 gene upstream
of the ERG20 gene. This valve diverts ﬂuxes to the orthogonal branch when sterol levels increase. TPS terpene synthase, CYPs cytochrome P450 enzymes,
ADHs alcohol dehydrogenases, GGPP geranylgeranyl diphosphate, PERG1 ERG1 promoter
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under these conditions, and most of it was channeled to FPP.
Therefore, Erg20p is very efﬁcient in utilizing GPP, reducing the
GPP pool and hindering monoterpene production. Thus, we set
out to engineer an orthogonal pathway that does not depend
on GPP.
Establishing efﬁcient NPP biosynthesis in yeast cells. A cDNA
fragment encoding SlNPPS1 was cloned into the yeast vector
pHTDHmyc under the PTDH3 constitutive promoter and
expressed in strain AM94. To monitor NPP synthesis, we also
introduced yeast codon-optimized versions of three different
NPP-speciﬁc monoterpene synthases, Solanum lycopersicum
phellandrene synthase (SlPHS1)28, Solanum habrochaites limo-
nene synthase (ShLimS)30, and S. habrochaites pinene synthase
(ShPinS)30. When expressed in yeast in the absence of SlNPPS1,
no new products were detected, as none of the three monoterpene
synthases were able to utilize the available GPP. However, upon
SlNPPS1 co-expression, all three synthases produced their
reported NPP-derived products. Speciﬁcally, SlPHS1 produced β-
phellandrene (48.6%), δ-2-carene (36.6%), α-phellandrene (8.3%),
and α-terpinene (6.5%). ShLimS produced limonene as a single
product, and ShPinS produced α-pinene (84%) and limonene
(16%) (Fig. 2a). Product titers in all cases were very low, ranging
from 0.009 mg L−1 α-pinene to 0.16 mg L−1 β-phellandrene
(Supplementary Table 2). Furthermore, we observed that AM94
cells engineered to express SlNPPS1 in the absence of any
monoterpene synthase produced detectable levels of nerol, as
conﬁrmed by comparison of mass spectra and retention time with
an authentic standard (Fig. 2b). By analogy to the formation of
geraniol via the hydrolysis of GPP by intracellular phosphatases
like Lpp1p and Dpp1p14,34, we attributed the production of nerol
to the hydrolysis of NPP that accumulated in the absence of a
suitable terpene synthase. Taken together, these results conﬁrmed
that the alternative substrate, NPP, is synthesized in the engi-
neered yeast strain and it can be used to produce monoterpenes.
To ensure that NPP can form the basis for an orthogonal
pathway, we conﬁrmed that it did not interfere with the rest of
the yeast isoprenoid metabolism. With a combination of in vitro
and in vivo experiments, we conﬁrmed that NPP was not taken
up by Erg20p to produce larger prenyl diphosphates. We
expressed Erg20p in Escherichia coli and used the puriﬁed protein
(Supplementary Fig. 4) in in vitro assays with GPP and NPP.
Although the recombinant enzyme was able to produce FPP from
IPP and GPP, it was not able to catalyze elongation of NPP. We
were also unable to detect any NPP-derived products of Erg20p in
yeast cells or in yeast cell extracts supplemented with NPP and
IPP (Supplementary Fig. 5). We also conﬁrmed that the growth
properties of SlNPPS1-expressing yeast cells were very similar to
their empty vector-containing counterparts (Supplementary
Fig. 6).
Redirecting ﬂux to the orthogonal pathway. The new branching
point established for monoterpene biosynthesis could function as
a valve to direct the ﬂux of substrates away from FPP synthesis
and to increase the monoterpene yield (Fig. 1). First, we aimed to
decrease the competition for IPP by Erg20p. To achieve this, we
introduced Erg20p(N127W), a dominant-negative Erg20p variant
that inhibits the FPP synthesis step of the endogenous wild-type
enzyme14,35. This resulted in a 3–4-fold increase (depending on
the enzyme) in the total monoterpene yield of all three NPP-
speciﬁc monoterpene synthases (Fig. 2c and Supplementary
Table 2).
Heterozygous gene deletions in yeast have been shown to
decrease the level of the corresponding protein to 50%36. Thus, to
further reduce the ﬂux through the FPP-synthesizing branch, we
downregulated Erg20p by shifting to the yeast strain MIC2, which
carries a deletion in one of the two ERG20 alleles14. This resulted
in a further 1.9–2.8-fold increase in monoterpene titer (Fig. 2c
and Supplementary Table 2).
Previous studies had shown that fusion of a heterologous enzyme
to Erg20p can be beneﬁcial for the enzyme’s stability37–39. We fused
SlNPPS1 to the C terminus of Erg20p(N127W) and conﬁrmed that
the fused protein reached higher intracellular levels compared with
the non-fused SlNPPS1 (Supplementary Fig. 7). We subsequently
introduced the Erg20p(N127W)–SlNPPS1 variant into strain MIC2
to achieve an additional 1.4–2-fold improvement in production. The
combination of these interventions resulted in an overall 12–18-fold
increase, reaching 2.7mg L−1 β-phellandrene, 2.5mg L−1 limonene,
and 0.11mg L−1 α-pinene (Fig. 2c and Supplementary Table 2).
Following these improvements, a signiﬁcant amount of nerol could
be detected in the NPP-producing cells overexpressing ShLimS,
ShPinS, or SlPHS1 (Fig. 2d and Supplementary Table 3). This
suggested that the combination of these interventions achieved
efﬁcient synthesis of NPP, but utilization of the alternative substrate
has reached a bottleneck at the level of the monoterpene synthases
that resulted in its accumulation and eventual conversion to nerol.
Canonical monoterpene synthases accept NPP as a substrate.
The accumulation of nerol indicated that the three NPP-speciﬁc
synthases tested here could not harvest the full potential of the
orthogonal pathway, and more efﬁcient biocatalysts were required.
However, only few NPP-speciﬁc synthases have been reported to
date28,30,40, limiting the possibility that a search to identify
enzymes more active than the synthases used here would be suc-
cessful. Furthermore, the product range of the known NPP-speciﬁc
enzymes was limited to only four main products, β-phellandrene28,
limonene30, α-pinene30, and nerol40. To identify enzymes that are
more active and to enable the production of a broad range of
different monoterpene scaffolds, we turned into the rich resource
of canonical, GPP-converting, plant monoterpene synthases. We
selected ﬁve synthases with different product proﬁles, including
ClLimS33, Salvia fruticosa 1,8-cineole synthase (SfCinS1)41, Salvia
pomifera sabinene synthase (SpSabS)41, Pinus taeda α-pinene
synthase (PtPinS)42, and Solanum elaeagnifolium camphene syn-
thase (SeCamS)43, and tested whether they can accept NPP as a
substrate. When introduced to strain MIC2 expressing Erg20p
(N127W), i.e., a GPP-synthesizing strain, all ﬁve enzymes pro-
duced their expected monoterpene products (Fig. 3). When Erg20p
(N127W) was replaced by the Erg20p(N127W)–SlNPPS1 fusion to
establish the production of NPP, an overall increase ranging
between 1.3- and 2.8-fold (depending on the enzyme) in mono-
terpene formation compared with the GPP-only producing strain
was achieved with all canonical monoterpene synthases (Fig. 3).
This suggested that the canonical enzymes could accept both
substrates, resulting in overall higher yields, and that the different
enzymes had varying capacity to accept the isomeric substrate. We
conﬁrmed that the selected monoterpene synthases were able to
utilize NPP in in vitro assays with bacterially expressed enzymes
(Supplementary Figs. 4 and 8a). We also examined the product
proﬁle of the ﬁve enzymes with NPP in vitro and found that four
of them synthesized almost the same blend of monoterpenes as
with GPP. Only the proﬁle of SeCamS shifted from camphene
toward limonene with NPP in vitro (Fig. 3e; Supplementary
Fig. 8a), which was reﬂected in the product proﬁle of NPP-
producing yeast cells expressing SeCamS (Supplementary Fig. 8b).
There was no new monoterpene product with any of the synthases
and NPP.
Kinetic analysis of the reaction with each isomeric substrate
revealed that the canonical synthases exhibited higher afﬁnity and
overall catalytic efﬁciency (kcatapp/KMapp) with GPP than with NPP
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(SfCinS1: 0.213min−1 μM−1 with GPP vs. 0.137min−1 μM−1 with
NPP; ClLimS: 0.735min−1 μM−1 with GPP vs. 0.456min−1 μM−1
with NPP; SeCamS: 0.21min−1 μM−1 with GPP vs. 0.044min−1
μM−1 with NPP; Table 1). Yet, the observation that yeast
productivity with ClLimS and PtPinS when both the GPP and the
NPP pathways were present was more than double, compared with
when only the GPP pathway was active (Fig. 3), provided two main
conclusions. First, it indicated that these terpene synthases were not
the limiting step of the pathway. Second, the ability of ClLimS and
PtPinS to support equal or higher titers with NPP, despite this not
being their preferred substrate, suggested that the established NPP-
based pathway was efﬁcient and had the potential to exceed the
GPP pathway in productivity. To further evaluate the performance
of the NPP-based pathway, we examined the kinetic characteristics
of SlNPPS1 using in vitro assays with enzymes expressed and
puriﬁed in E. coli (Supplementary Fig. 4). The determined kinetic
parameters revealed that SlNPPS1 is signiﬁcantly less efﬁcient than
Erg20p in utilizing DMAPP and IPP (Supplementary Table 4;
refs. 14,28). Combined with the preference of canonical terpene
synthases for GPP rather than NPP (Table 1), we concluded that
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the observed increase in productivity is not due to favorable kinetics
of the SlNPPS1 branch.
The canonical monoterpene synthases convert GPP and NPP
to the same blend of products (Supplementary Fig. 8), not
allowing to determine the relative contribution of the two
substrates simply by examining the product proﬁle. To resolve
this, we synthesized 13C-labeled NPP (Supplementary Fig. 9), so
as to distinguish the products of each substrate when mixtures of
the labeled compound with unlabeled GPP were used. We added
precursors to extracts of yeast cells expressing ClLimS and
determined the isotopic composition of the produced limonene
using GC–APCI–QqToF analysis. In these experiments, 13C-NPP
was initially shown to be channeled efﬁciently to limonene
synthesis, while GPP was mostly consumed to produce FPP
(Supplementary Figs. 10 and 11). In subsequent competition
experiments between 13C-labeled NPP and GPP, when the two
isomeric substrates were added at equal concentrations, over 90%
of the limonene produced originated from 13C-NPP. The
contribution of the two substrates to limonene production was
comparable, only when GPP was in tenfold excess (Supplemen-
tary Fig. 12a).
Comparison of the overall production titers revealed that
ClLimS and PtPinS were 24 and 224 times more efﬁcient,
respectively, in limonene and α-pinene synthesis in NPP-
producing yeast cells than their NPP-speciﬁc counterparts,
ShLimS and ShPinS (Supplementary Table 5). Taken together,
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Fig. 3 Monoterpene production by canonical terpene synthases. Five different monoterpene synthases were overexpressed in yeast cells producing solely
GPP (brown), or also producing NPP as an alternative substrate (green). The monoterpene product titers increased markedly when NPP was also available
with all synthases tested: Salvia fruticosa 1,8-cineole synthase (SfCinS1) (a), Pinus taeda α-pinene synthase (PtPinS) (b), Citrus limon limonene synthase
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limonene was observed in the product proﬁle of SeCamS with NPP. Yeast cells producing NPP in the absence of any monoterpene synthase are shown as
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Table 1 Kinetic parameters of terpene synthases and variants
Enzyme variant Substrate kcatapp (min−1) KMapp (μM) kcatapp/KMapp (min−1 μM−1)
SfCinS1 wild type GPP 5.56 ± 0.38 26.12 ± 2.79 0.213
SfCinS1 wild type NPP 12.2 ± 2.67 89.46 ± 4.99 0.137
SfCinS1(F571Y) GPP 0.37 ± 0.03 29.93 ± 6.14 0.012
SfCinS1(F571Y) NPP 0.75 ± 0.12 37.48 ± 14.26 0.020
SfCinS1(F571H) GPP 0.86 ± 0.09 18.05 ± 5.07 0.048
SfCinS1(F571H) NPP 0.74 ± 0.08 238.1 ± 34.35 0.003
SfCinS1(F571V) GPP 0.32 ± 0.08 271.5 ± 95.30 0.001
SfCinS1(F571V) NPP 0.45 ± 0.04 67.24 ± 13.30 0.007
SfCinS1(F571L) GPP 0.44 ± 0.07 55.72 ± 9.22 0.008
SfCinS1(F571L) NPP 0.64 ± 0.08 71.82 ± 17.63 0.009
ClLimS wild type GPP 18.34 ± 0.88 24.94 ± 3.76 0.735
ClLimS wild type NPP 37.16 ± 1.76 81.55 ± 7.33 0.456
ClLimS(H570F) GPP 14.64 ± 2.50 12.86 ± 7.20 1.138
ClLimS(H570F) NPP 29.70 ± 1.82 31.94 ± 5.14 0.930
ClLimS(H570Y) GPP 8.92 ± 0.43 11.76 ± 4.82 0.759
ClLimS(H570Y) NPP 21.86 ± 1.66 23.98 ± 6.41 0.911
ClLimS(H570L) GPP 0.24 ± 0.07 16.89 ± 6.72 0.014
ClLimS(H570L) NPP 4.58 ± 0.66 110.5 ± 19.30 0.041
ClLimS(H570V) GPP 1.16 ± 0.08 56.70 ± 12.42 0.021
ClLimS(H570V) NPP 1.24 ± 0.10 32.44 ± 14.14 0.038
ClLimS(H570I) GPP 0.21 ± 0.02 24.43 ± 6.44 0.009
ClLimS(H570I) NPP 1.90 ± 0.13 27.06 ± 4.72 0.070
SeCamS wild type GPP 3.91 ± 0.22 18.58 ± 2.77 0.210
SeCamS wild type NPP 4.82 ± 0.39 107.49 ± 12.48 0.044
Errors represent standard error of the ﬁtted parameters. Source data are provided in a Source Data ﬁle
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these ﬁndings conﬁrmed that canonical monoterpene synthases
can serve as efﬁcient surrogate synthases in this synthetic pathway
and suggested that canonical enzymes could offer a starting point
for protein engineering efforts to improve NPP utilization.
Engineering NPP-speciﬁc monoterpene synthases. To fully
exploit the potential of the orthogonal pathway, we set out to
engineer the selected canonical monoterpene synthases, with the
aim to increase their efﬁciency and speciﬁcity for NPP. Initially,
we focused on SfCinS1 due to the availability of structural infor-
mation and our previous experience in engineering this enzyme to
alter its substrate and product speciﬁcity41. In these efforts, we
developed a library of 19 variants at different positions in the
active site39,41. Here, we differentially screened this library in
GPP- and NPP-producing yeast strains to identify sites that
potentially inﬂuence substrate speciﬁcity. As shown in Fig. 4a, one
site, F571, stood out as playing a critical role in selecting between
the two isomeric substrates, as several variants at this position
were able to markedly improve the performance of the enzyme
with NPP. Variants SfCinS1(F571V), SfCinS1(F571Y), and
SfCinS1(F571I) were 18, 9, and 7 times more efﬁcient, respectively,
when the NPP pathway was present, compared with their per-
formance with only GPP as a substrate (Fig. 4a). Although the
catalytic efﬁciency of the variants was lower than that of the wild-
type enzyme (Supplementary Table 6), these ﬁndings suggested
that F571 may be acting as a switch that differentiates substrate
preference between NPP and GPP. In addition to F571, certain
substitutions in a second residue, N338, also resulted in shifts in
speciﬁcity, albeit in a less efﬁcient or consistent manner. Variants
SfCinS1(N338A) and SfCinS1(N338S) exhibited an opposing
substrate selectivity. SfCinS1(N338A) became a strictly GPP-
utilizing enzyme, while SfCinS1(N338S) was 6.7 times more efﬁ-
cient when the NPP pathway was present (Fig. 4a). To test for
potential synergistic effects, we also constructed several variants
combining F571 substitutions with substitutions in the other
positions (Supplementary Table 7). However, no further
improvements in substrate speciﬁcity were observed (Fig. 4a). For
further studies, we focused exclusively on the role of F571, because
of the extent and consistency of speciﬁcity changes.
Analysis of the structural information available for SfCinS141
in the context of biochemical and structural studies on the
enzymatic mechanism of monoterpene synthases44 provided
insight into the possible role of F571. As shown in Fig. 4b, the
early steps of the canonical monoterpene synthase mechanism
involve the initial binding of GPP in an extended conformation,
followed by the ionization of the substrate and the syn migration
of the diphosphate moiety to C-3. The resulting linalyl dipho-
sphate (LPP) maintains the transoid conformation of GPP
(Fig. 4b). Thus, for cyclization to take place, the C-2,3 bond
must rotate to convert LPP from the transoid to the cisoid
conformer. Subsequent conformational change of LPP to the
closed conﬁguration brings C-6 and C-1 to a position competent
for cyclization. Following cyclization, the resulting carbocations
rearrange to ﬁnally yield different hydrocarbons (Fig. 4b). Due to
the cisoid conformation of NPP, its cyclization does not require
the same transition from the transoid to the cisoid form (Fig. 4b).
As shown in Fig. 4b, in the structure of SfCinS1, F571 is
positioned at a short distance from C-1 of LPP. This analysis
suggested two possible explanations for the ability of F571 to
control isomeric substrate selectivity. Considering the extensive
conformational changes that are required for the substrate to
transition from the transoid to the cisoid form (compare the
structure of the two intermediate analogs in Fig. 4b), one scenario
would be that F571 plays a direct role in this process. In this case,
substitutions in F571 that impair the transoid to cisoid transition
would have a negative impact in the GPP-based reaction, but
would not interfere with the transition-independent NPP
reaction. Alternatively, F571 may not be directly involved in the
transition process; instead, the size and orientation of the side
chain at position 571 may alter the geometry of the active site to
favor binding of one substrate versus the other. To distinguish
between these two mechanisms, we conducted a detailed kinetic
analysis of SfCinS1 mutants. SfCinS1(F571V), SfCinS1(F571Y),
and SfCinS1(F571L) showed shifts in KMapp either favoring NPP
binding or disfavoring binding of GPP (Table 1), suggesting that
the residue at position 571 exerts stereochemical control. In
agreement, the reverse behavior of SfCinS1(F571H), which
showed preference for GPP in vivo, was the result of a signiﬁcant
increase in KMapp for NPP.
We explored whether residues analogous to F571 in the other
canonical monoterpene synthases play a similarly critical role.
Based on amino acid sequence alignment (Supplementary
Fig. 13), candidate residues in the other monoterpene synthases
were identiﬁed and substituted with aromatic or aliphatic side
chains of different size using site-directed mutagenesis
(Supplementary Table 7). As shown in Fig. 5, in all four
enzymes tested, we were able to identify variants at this position
that shift substrate selectivity to NPP. Speciﬁcally, in ClLimS, all
H570 variants showed higher preference for NPP than the wild-
type enzyme in the yeast system (Fig. 5a, left panel). Among
them, ClLimS(H570Y) and ClLimS(H570F) also achieved
improved performance in NPP-based monoterpene production
in yeast (Fig. 5a, right panel). In ClLimS(H570Y), this was the
result of a twofold improvement on the catalytic efﬁciency
(kcatapp/KMapp) with NPP, which was mostly due to a lower
KMapp with NPP and a decreased kcatapp with GPP (Table 1). In
the case of ClLimS(H570F), the higher overall productivity in
the yeast system was the result of improved binding of both
substrates. ClLimS(H570I), ClLimS(H570L), and ClLimS
(H570V) were even more speciﬁc for NPP (Fig. 5a, left panel),
as manifested by an eightfold higher kcatapp/KMapp in ClLimS
(H570I) and a threefold higher kcatapp/KMapp in ClLimS(H570L)
(Table 1). However, the overall efﬁciency of these variants was
low and could not sustain high-product titers (Fig. 5a, right
panel; Table 1). We evaluated ClLimS(H570Y) in competition
experiments using yeast extracts and 13C-NPP. ClLimS(H570Y)
was markedly more efﬁcient than wild-type ClLimS in harvest-
ing NPP ﬂuxes, and even when GPP was present at a tenfold
excess over 13C-NPP, over 75% of the products were derived
from 13C-NPP (Supplementary Fig. 11b).
In SpSabS, substitution of H561 with F resulted in a highly
efﬁcient biocatalyst, with an almost threefold improved apparent
speciﬁcity for NPP in yeast compared with the wild-type enzyme
(Fig. 5b, left panel) and an overall 2.5-fold improvement in
performance when the NPP pathway was present (Fig. 5b; right
panel). We were not able to obtain active recombinant SpSabS
(H561F) to determine the kinetic parameters underlying these
improvements. In the case of SeCamS, substitution of H583
resulted in drastic changes in speciﬁcity and activity. Variants
SeCamS(H583F) and SeCamS(H583V) became limonene-
synthesizing enzymes that exhibited three -times higher apparent
selectivity for NPP compared to wild-type SeCamS (Fig. 5c, left
panel). These two variants improved overall NPP-based produc-
tion in yeast by 11 and 9 times, respectively (Fig. 5c, right panel
and Fig. 5e). Finally, in PtPinS, four out of ﬁve variants of
F607 switched speciﬁcity to NPP in the yeast system (Fig. 5d),
nevertheless, with lower activity than the parental enzyme.
Overall, these results revealed a conserved role for F571 in
SfCinS1, and the corresponding residues in the other synthases, in
dictating substrate selectivity. The identiﬁcation of such a key
residue in the terpene synthase active site reveals fundamental
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mechanistic details of these enzymes and will be invaluable for
future protein engineering efforts aiming to expand the synthetic
pathway developed here with additional synthases.
Improving titers and enabling downstream oxidation steps.
Using the NPP-speciﬁc synthases developed here, we were able to
harvest the orthogonal pathway established to produce mono-
terpenes with considerably higher efﬁciency than only with the
GPP-dependent pathway. In shake-ﬂask batch cultivation of
strain MIC2 expressing the Erg20p(N127W)-SlNPPS1 fusion, the
ClLimS(H570Y)-supported limonene titer reached 130 mg L−1,
while SpSabS(H561F) enabled the production of 72.7 mg L−1
sabinene (Supplementary Table 8). Furthermore, the engineered
synthases were quite efﬁcient in harvesting NPP, leading to a
signiﬁcant reduction in nerol production from excess NPP
(Supplementary Table 8). Engineering efﬁcient monoterpene
scaffold production in yeast is of particular interest because yeast
cells offer an advantage over prokaryotic hosts for the functional
expression of cytochrome P450 enzymes, which are required for
the synthesis of more complex monoterpenoids. So far, low
monoterpene titers have hindered efﬁcient P450 catalyzed oxi-
dation of monoterpenes by a yeast cell factory. We evaluated
whether the overall improvements obtained here were sufﬁcient
to enable downstream oxidation steps by introducing the sabi-
nene hydroxylase CYP750B145 from T. plicata, together with a
compatible cytochrome P450 oxidoreductase38,46, to establish
production of trans-sabin-3-ol. While production of trans-sabin-
3-ol was not detectable when only the GPP pathway was used, we
were able to synthesize detectable amounts of trans-sabin-3-ol in
the NPP-producing MIC2 strain using wild-type SpSabS. The
levels of trans-sabin-3-ol increased three times when the NPP-
speciﬁc SpSabS(H561F) variant was used instead of SpSabS
(Fig. 5f; Supplementary Fig. 14).
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Dynamic regulation of the orthogonal pathway. The metabolic
valve created at the point of DMAPP and IPP condensation can be
dynamically controlled to divert ﬂuxes towards NPP in response
to internal metabolite levels. A key metabolite in our system is
ergosterol, the main yeast sterol. To minimize ﬂux to the sterol
branch when adequate levels of ergosterol were synthesized, we
implemented a dynamic design based on the promoter of the
ERG1 gene. Expression of ERG1 is negatively regulated by
ergosterol via an ergosterol-responsive regulatory element in its
promoter (PERG1)47. A similar design was previously exploited to
improve production of the sesquiterpene amorpha-4,11-diene by
controlling ERG948, and of the diterpene casbene by controlling
both the ERG9 and ERG20 genes49. To dynamically regulate FPP
synthesis in response to ergosterol levels in our system, we
replaced the promoter of ERG20 in strain MIC2 with an 807 bp
region of PERG1 that contains the ergosterol-responsive element to
give rise to strain MIC3. Using the engineered NPP-speciﬁc syn-
thases and strain MIC3, we were able to produce monoterpenes
with considerably higher efﬁciency than with the native GPP-
based pathway. In semi-batch shake-ﬂask cultivation, ClLimS
(H570Y)-supported limonene titer in MIC3 strain reached 166
mg L−1, which is 6.8-times higher than the titer obtained in GPP-
only producing MIC2 cells with wild-type ClLimS (Fig. 5e and
Table 2). Similarly, with SpSabS(H561F), we obtained 113mg L−1
sabinene under dynamic regulation (MIC3), which was 7.1 times
higher than the highest titer obtained in MIC2 by the native
pathway and SpSabS (Fig. 5e and Table 3).
Discussion
We established a synthetic pathway for monoterpenoid synthesis
based on an alternative terpene synthase substrate and engineered
terpene synthases that preferentially utilize the isomeric substrate.
This orthogonal pathway was more efﬁcient than the native GPP-
based pathway. Using kinetic studies and competition experi-
ments with 13C-labelled substrates, we conﬁrmed that the basis
for the improved performance of the NPP-based pathway is that
NPP, unlike GPP, is not consumed by Erg20p to produce sterols.
Construction of the orthogonal pathway established a metabolic
valve at the point of DMAPP and IPP condensation, enabling its
dynamic control4–8,47. In future efforts, additional titer
improvements can be achieved by incorporating more elaborate
control mechanisms, such as engineered degradation of Erg20p23
or metabolic modeling to identify additional targets for dynamic
regulation9. This approach has wider implications for the engi-
neering of other high-value compounds where isomers can pro-
vide orthogonality, providing a blueprint for applying synthetic
pathway design50 and orthogonality considerations3 in the engi-
neering of biological production systems.
Until now, efforts in monoterpene bioproduction have been
more efﬁcient when using bacterial hosts51–54. However, engi-
neering the downstream steps of monoterpenoid biosynthesis in a
bacterial chassis is challenging because several of these steps
require the functional expression of cytochrome P450 enzymes,
which is not readily achieved in bacteria55. In addition, several
monoterpenoids exhibit signiﬁcant toxicity to bacteria by inter-
fering with the cell membrane, compromising its integrity and
impacting the function of membrane-bound enzymes13,56–58.
Furthermore, accumulation of terpenoid pathway precursors,
such as IPP, has been found to have a negative impact on bac-
terial growth59. For these reasons, engineering efﬁcient produc-
tion of monoterpene scaffolds in yeast can be beneﬁcial. This is
highlighted here by the markedly improved production of trans-
sabin-3-ol using the orthogonal pathway.
These ﬁndings also make an important contribution to our
understanding of the enzymatic mechanism of monoterpene
synthases. The identiﬁcation of a single residue with a consistent
function in dictating isomeric substrate selectivity in the active
site of all monoterpene synthases tested points to an evolutio-
narily conserved role and provide important knowledge for the
engineering of NPP-speciﬁc monoterpene synthases. This, in
turn, will help expand the platform presented here with addi-
tional highly efﬁcient synthases for numerous other monoterpene
scaffolds. Furthermore, the residue corresponding to SfCinS1
(F571) appears to play a multifaceted role in monoterpene syn-
thases, as it has also been found to enable enzymes to differentiate
between GPP and 2-methyl-GPP39.
The vast majority of known terpenoids are synthesized from
substrates with a trans conﬁguration. Although the cis forms of
the universal canonical diterpene precursors Z,Z-FPP and ner-
ylneryl diphosphate (NNPP) have been reported in some
organisms, very few cis-prenyl diphosphate-derived compounds
Table 2 Production of limonene in semi-batch conditions
Protein expressed Limonene (mg L−1)
in MIC2
Nerol (mg L−1)
in MIC2
Limonene (mg L−1)
in MIC3
Nerol (mg L−1)
in MIC3
Erg20p(N127W)+ ClLimS wt 23.31 ± 5.97 – 41.49 ± 3.95 –
Erg20p(N127W)+ ClLimS(H570Y) 27.51 ± 5.04 – 86.30 ± 10.76 –
Erg20p(N127W)-SlNPPS1+ ClLimS wt 62.47 ± 15.32 0.542 71.84 ± 13.98 0.042
Erg20p(N127W)-SlNPPS1+ ClLimS(H570Y) 126.19 ± 18.97 0.023 167.38 ± 20.88 0.015
Errors correspond to the mean absolute deviation (MAD) around the mean (n= 3 biologically independent samples). Source data are provided in a Source Data ﬁle
Table 3 Production of sabinene in semi-batch conditions
Protein expressed Sabinene (mg L−1)
in MIC2
Nerol (mg L−1)
in MIC2
Sabinene (mg L−1)
in MIC3
Nerol (mg L−1)
in MIC3
Erg20p(N127W)+ SpSabS wt 23.31 ± 5.97 – 41.49 ± 3.95 –
Erg20p(N127W)+ SpSabS(H561F) 27.51 ± 5.04 – 86.30 ± 10.76 –
Erg20p(N127W)-SlNPPS1+ SpSabS wt 62.47 ± 15.32 0.542 71.84 ± 13.98 0.042
Erg20p(N127W)-SlNPPS1+ SpSabS(H561F) 126.19 ± 18.97 0.023 167.38 ± 20.88 0.015
Errors correspond to the mean absolute deviation (MAD) around the mean (n= 3 biologically independent samples). Source data are provided in a Source Data ﬁle
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have been reported so far28,60–63. It is unclear what has led to this
stereochemical specialization through evolution, but further
expansion of the platform developed here to produce Z,Z-FPP
and NNPP combined with protein engineering of canonical ter-
pene synthases, could provide access to sesquiterpene and diter-
penoid compounds that are rare or not found in nature.
Methods
Chemicals and enzymes. Standards used include cis-3,7-dimethyl-2,6-octadien-1-
ol (Aldrich, 268909-5ML), α-pinene (Aldrich, P-7408), β-myrcene (Sigma, M-
0382), 1,8-cineole (Aldrich, C8,060-1), γ-terpinene (Aldrich, T2134), limonene
(Sigma-Aldrich, 62118), camphene (Sigma-Aldrich, 456055), alpha-phellandrene
(Sigma-Aldrich, W285611), 2-carene (Sigma-Aldrich, 232386), beta-phellandrene
(Carbosynth, FB158830), linalool (Aldrich, L2602), and a 70% sabinene solution
(kindly donated by VIORYL S.A., Athens, Greece). Phusion High-Fidelity DNA
Polymerase (New England BioLabs, M0530S) and MyTaq DNA polymerase (BIO-
21105, Bioline) were used in PCR ampliﬁcations. The QIAquick Gel Extraction Kit
(#28704, Qiagen) was used for gel extraction and DNA puriﬁcation. The
NucleoSpin Plasmid Kit (740588.250, Macherey-Nagel) was used for plasmid DNA
puriﬁcation. Restriction enzymes used were from New England BioLabs.
Yeast media. D-(+)-glucose monohydrate (16301, Sigma); D-(+)-galactose
(MG05201, CarboSynth); D(+)-rafﬁnose pentahydrate (OR06197, CarboSynth);
Yeast Nitrogen Base w/o AA (Y2025, US Biologicals); Complete Minimal (CM)
medium was composed of 0.13% (w/v) dropout powder (all essential amino acids),
0.67% (w/v) yeast nitrogen base w/o AA, 2% glucose; For galactose- based medium,
glucose was substituted with 2% galactose and 1% rafﬁnose.
Construction of MIC3 yeast strain. The promoter region of ERG1 was ampliﬁed
from genomic DNA of BY4741 yeast strain using primers SalI-Perg1-FP and
Perg1-HindIII-RP to introduce the restriction sites SalI at the 5′-end and HindIII at
the 3′-end. The PCR product was inserted into a pCR2.1-TOPO vector by TOPO
TA Cloning (450641, Thermo Fisher Scientiﬁc) and conﬁrmed by sequencing.
Subsequently, the pTOPO-PERG1 plasmid was digested with SalI/HindIII, and the
DNA fragment corresponding to the ERG1 promoter was gel puriﬁed and inserted
into pCOD724 linearized with SalI/HindIII to generate plasmid COD71 (PERG1-
CYC1t, LoxP-HIS5-LoxP). The COD71/PERG1 cassette was PCR ampliﬁed using
primers COD71-ERG20-FP and COD71-ERG20-RP, adding ﬂanking regions
complementary to the 5′ and 3′ end the native promoter of ERG20 gene. Following
transformation into strain MIC2, correct integration was conﬁrmed by PCR using
ERG20-gseq-FP and ERG20-gseq-RP.
Gene cloning and expression in yeast. Supplementary Table 7 contains all pri-
mers used in cloning procedures described below.
For cloning of SlNPPS1, the mature form of SlNPPS1 lacking the presumed N-
terminal transit sequence (1–44 a.a.) (NM_001247704), was ampliﬁed by PCR
using primers SlNPPS1-S45BamHI and SlNPPS1-3XhoI. The amplicon was cloned
into a bacterial plasmid using the TOPO TA kit (Invitrogen) and validated by
Sanger sequencing. SlNPPS1 was subcloned into the yeast vector pHTDH3myc and
in the bacterial vector pRSETa using the BamHI and XhoI sites.
Fusion of the SlNPPS1 with ERG20(N127W) was initiated by digestion of
pYESmyc/ERG20(N127W)-5XGS14 with EcoRI and XhoI to generate a linearized
fragment. The SlNPPS1 gene was ampliﬁed with SlNPPS1-5EcoRI and SlNPPS1-
3XhoI and introduced into pCRII-TOPO vector by TOPO cloning. Subsequently,
the SlNPPS1 fragment was released from the above generated construct through
restriction digestion with EcoRI and XhoI. The obtained fragments of pYESmyc/
ERG20(N127W)-GS and SlNPPS1 were ligated to generate pYESmyc/ERG20
(N127W)-5XGS-SlNPPS1 construct.
Cloning of the TPSs in compatible yeast expression proceeded through the
following steps A yeast codon-optimized version of Citrus limon (+)-S-limonene
synthase (ClLimS) (GenBank AF514287.1) was PCR ampliﬁed from pCEV-G2-Ph/
ClLimS64 using primers LimS-BGL and LimS-XHOstop to introduce BglII and
XhoI restriction sites at the 5′ and 3′ ends, respectively. Initially a TOPO cloning
reaction was performed to clone the PCR product into vector pCRII-TOPO.
Subsequently, the pCRII-TOPO/ClLimS construct was digested using BglII and
XhoI restriction enzymes and the ClLimS fragment was excised and subcloned into
vector pWTHD3myc27 linearized with BamHI and XhoI. In this construct, ClLimS
was expressed under the control of the PTDH3 promoter. Yeast codon-optimized
versions of S. lycopersicum phellandrene synthase (SlPHS1) (FJ797957.1)28,
S. habrochaites limonene synthase (ShLimS) (AFJ67826.1)30, S. habrochaites pinene
synthase (ShPinS) (AFJ67816.1)30, and P. taeda α-pinene synthase (PtPinS)
(GenBank Q84KL3.1)42, lacking the transit peptide, were obtained by gene
synthesis. In addition, the synthetic fragments bear ﬂanking regions containing
speciﬁc restriction sites and a generic sequence compatible for USER cloning. The
above genes were ampliﬁed and cloned by USER cloning into a generic backbone
using primers USER-Gen-FP and USER-Gen-RP. BamHI site and SalI sites were
introduced at the 5′ and 3′ end, respectively. The constructs were conﬁrmed by
sequencing. Subsequently, the genes of interest were excised from the generic USER
vector by BamHI and SalI digestion and ligated under the PGAL1 promoter into the
pESC-TRP vector (Agilent Technologies, Cat. #217453) restricted with BamHI and
SalI enzymes. This approach resulted in the construction of the following plasmids:
pESC-TRP/SlPHS1, pESC-TRP/ShLimS, pESC-TRP/ShPinS, pESC-TRP/PtPinS.
Constructs of S. fruticosa 1,8-cineole synthase (SfCinS1) (GenBank ABH07677.1),
S. pomifera sabinene synthase (SpSabS) (GenBank DQ785794.1) and SeCamS in
appropriate yeast vectors were available from previous work14,41,43,65.
A yeast codon-optimized version of T. plicata CYP750B1 (KP004988)45 was
obtained by gene synthesis, bearing ﬂanking regions containing speciﬁc restriction
sites and a generic sequence compatible for USER cloning. The corresponding
DNA fragment was ampliﬁed and cloned into a generic backbone by USER
technology using the primers: USER-Gen-FP and USER-Gen-RP (Supplementary
Table 7). Subsequently, the gene encoding CYP750B1 was excised from the generic
USER vector by BamHI and SalI digestion and ligated under the PGAL1 promoter
into pESC-HIS vector (Agilent Technologies, Cat. #217453) linearized with BamHI
and SalI enzymes. The generated plasmid, pESC-HIS/TpCYP750B1, was conﬁrmed
by sequencing. A construct (pYX143/ PtCPR2) containing the gene encoding
NADPH-cytochrome P450 reductase from Populus trichocarpa (PtCPR2)46 was
already available38.
Expression in yeast of CYP750B1. Subsequently, MIC2 yeast cells were co-
transformed with four expression vectors bearing different auxotrophic markers:
pYES2myc for expression of Erg20p(N127W) or Erg20p(N127W)-SlNPPS1 using
uracil selection, pJG4-4 for expression of SpSabS wt and mutants (H561F or
H561Y) under tryptophan selection, pYX143 for expression of PtCPR2 under
leucine selection, and pESC-HIS for expression of TpCYP750B1 using histidine
selection. PtCPR2 was expressed from pYX143 (PTPI1, LEU2, cen) to achieve low
level protein expression because this was found to have a positive effect on P450
activity38. All other proteins (Erg20p, SlNPPS1, SpSabS, and TpCYP750B1) were
expressed under the strong inducible promoter PGAL1 and from high copy number
(2μ) vectors. Sabinene-producing transformants expressing TpCYP750B1/ PtCPR2
were cultured and analyzed by SPME using GC–MS.
Terpene quantiﬁcation and extraction from yeast cells. Selected S. cerevisiae
strains were grown overnight at 30 °C and 150 rpm and subsequently induced in 2-
mL liquid media using 20-mL glass vials with magnetic screw cap (Mikrolab
Aarhus A/S). Solid phase microextraction (SPME) was applied for measuring the
volatile terpenes produced in yeast cells after 48 h of culturing, using a 2 cm-50/
30 µm DVB/Carboxen™/PDMS StableFlex™ ﬁber followed by GC–MS analysis
(described below)65. For quantiﬁcation, terpene extraction was performed using 1%
(w/v) Diaion HP20 (Supelco, Bellefonte, PA) as adsorbent resin or overlay of the
yeast culture with 10% dodecane14,66,67 and GC-FID analysis. Prior to addition to
the yeast culture, the HP20 resin was activated in 100% methanol. Following
culturing, the beads were collected and washed with H2O to remove the yeast cells.
Subsequently, the beads were eluted three times with ethanol, followed by three
pentane elutions including 20–30 min incubation between each step. The pentane
phase was initially extracted with equal volume of water and then concentrated to a
100-μL ﬁnal volume and analyzed. Samples obtained from three separate yeast
transformations were processed and analyzed independently.
Fed batch cultures. Saturated overnight yeast cultures were used to inoculate
10 mL of glucose-based CM selective medium to an OD600= 0.1, which were
incubated at 30 °C at 150 rpm shaking until an OD600= 1. The pellets were washed
twice with sterile ddH2O and resuspended in 10 mL of 2× galactose/rafﬁnose-based
CM-selective medium. The cultures were overlaid with 2 mL of dodecane con-
taining 1 ppm isopropyl myristate as internal standard, grown at 30 °C at 150 rpm
shaking speed and fed with 1 mL of 20× galactose/rafﬁnose-based CM selective
media after 24, 48, 72, and 96 h. Cultures were stopped after 6 days of cultivation
and the dodecane phase was collected and diluted 1:100 in hexane containing
1 ppm squalene internal standard. Following GC-FID analysis, samples were
quantiﬁed by comparison of retention time and peak area to that of standard
curves of limonene and sabinene authentic standard.
Enzyme expression and puriﬁcation. Enzymatic activity of terpene synthases,
SlNPPS1 and Erg20p with GPP and NPP was evaluated with E. coli-produced and
puriﬁed recombinant enzyme and with yeast cell extracts. Wild-type and mutant
6×His-tagged TPSs39,41, SlNPPS128, and Erg20p14,37 were puriﬁed by Ni2+-NTA
afﬁnity chromatography from 200mL cultures of E. coli BL21 DE3 growing in LB
media at 19 °C14,37,39. Protein expression was induced by addition of 0.1 mM IPTG
the cells were grown overnight at 19 °C. Subsequently, protein puriﬁcation was
performed by afﬁnity chromatography using Ni-NTA agarose resin (Qiagen).
Brieﬂy, cells were disrupted by sonication in lysis buffer (60 mM Tris, pH 8, 20 mM
β-mercaptoethanol, 0.35M NaCl, 10 mM imidazole, 10% (w/v) glycerol, 1 mM
PMSF, 1 mg/mL lysozyme)41. Following removal of the cell debris via centrifuga-
tion 2400 × g and 4 °C, the protein lysate was incubated with Ni-NTA agarose resin
for 1 h at 4 °C with mild shaking. The protein was washed twice and eluted from
the resin using 350 mM imidazole.
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Enzymatic assays. Terpene synthase activity was assayed in a 0.5-mL reaction
containing 20 mM MOPS (pH 7.0), 20 mM MgCl2, 0.02 mM MnCl2, 1 mM DTT,
0.1 mg mL−1 BSA, 50 ng enzyme and varying concentrations (0–150 µM) of sub-
strate (GPP or NPP). The reaction was overlaid with an equal volume of hexane
containing 1 ppm nonane and 1 ppm dodecane as internal standards and incubated
for 1 h at 30 °C. The hexane phase was recovered and 2 μL were analyzed by
GC–MS9,41. Prenyl diphosphate synthase activity was assayed in a 0.2-mL reaction
containing 10 mM MOPS (pH 7.0), 5 mM MgCl2, 1 mM DTT, 0.1 mg mL−1 BSA,
0.02 mM IPP, and 50 ng of recombinant Erg20p. GPP or NPP substrates were
added at 0.02 mM. Reactions were terminated by addition of an equal volume
(0.2 mL) of 2 N HCl in 83% ethanol and 0.2 mL of hexane. Following a 20 min
incubation at 37 °C to allow diphosphate hydrolysis, reactions were neutralized
with 0.2 mL of 10% NaOH. A 2-μL aliquot of the hexane phase of an in vitro
enzymatic assay was analyzed by GC–MS. SlNPPS1 enzymatic activity was assayed
in the same conditions as for Erg20p11, using 50 ng of puriﬁed enzyme, 0.05 mM of
IPP or DMAPP, and varying concentrations (0–0.2 mM) of DMAPP or IPP,
respectively. Reactions were incubated for 1 h at 30 °C and stopped by acid
treatment. Kinetic analysis was performed using WinCurveFit 1.1.8 (Kevin Raner
software). Yeast cells obtained from a 10-mL culture were resuspended in 10 mM
MOPS (pH 7.0), 5 mM MgCl2, and 1 mM DTT and disrupted by glass beads. The
resulted yeast extracts were used in enzymatic assays as described above for bac-
terial puriﬁed terpene synthases and prenyl diphosphate synthases.
Competition assays. Yeast extracts obtained as described above from cells
expressing SlNPPS1, Erg20p, ClLimS wild-type or ClLimS(H570Y) were used in
0.5-mL reaction containing 20 mM MOPS, 20 mM MgCl2, 0.02 mM MnCl2, 1 mM
DTT, 0.01% (v/v) BSA, and varying concentrations of IPP, DMAPP, GPP, NPP,
13C-GPP, or 13C-NPP. The reactions were overlaid with hexane containing 1 ppm
nonane and 1 ppm dodecane as internal standards and incubated for 1 h at 30 °C.
Parallel reactions for hexane extraction and acid treatment following hexane
extraction were performed14,37. The hexane phase (2 μL) was analyzed by GC-FID
for product quantiﬁcation and by GC–qTOF for detection of the 13C isotope
incorporated in reaction products.
Yeast growth assay. AM94 cells harboring the pTDH3myc/SlNPPS1 construct or
the empty pTDH3myc vector were grown in glucose-based media at 30 °C and
150 rpm for 20 h. Yeast growth was monitored by measuring the optical density at
600 nm at regular intervals. No difference in the growth curve was observed in
yeast cells expressing SlNPPS1 under the PTDH3 constitutive promoter in com-
parison to cells carrying the empty vector.
Toxicity assays. Two different assays were considered to evaluate the limitation
imposed on monoterpene production in yeast cells due to possible toxicity
exhibited by these molecules to S. cerevisiae. The selected monoterpenes were
limonene and sabinene. To assess the effect of monoterpene on yeast growth,
AM94 yeast cells were used to inoculate 20 mL media to OD600 ~0.05 (considered
time 0). The cultures were overlaid with dodecane treated with varying con-
centrations of limonene or sabinene, respectively, to a ﬁnal concentration of 0, 30,
100, and 500 mg L−1 and incubated at 30 °C with 150 rpm shaking. The yeast
cellular growth was monitored by OD600 measurements taken every 2 h over a
period of time of 34 h. For OD600 values higher than 1, samples were diluted
accordingly.
To evaluate the effect of limonene accumulation, yeast cells expressing ClLimS
(100 µL) were used to inoculate 10 mL of galactose/rafﬁnose-based CM-selective
media overlaid with 10% dodecane containing varying concentration of limonene
(0 mg L−1, 300 mg L−1, and 1 g L−1) and incubated for 48 h at 30 °C with 150 rpm
shaking. Subsequently, the dodecane phase was recovered as described above and
analyzed by GC-FID. The limonene exceeding the starting concentration was
considered to be synthesized by yeast cells.
GC–MS analysis. GC–MS analysis was carried out using a ZB-5ms column and
helium as a carrier gas with a constant velocity of 37 cm/s. Samples resulting from
incubation of the SPME ﬁber for 30min over the head space of the yeast cultures were
analyzed using the following temperature program: initial temperature 60 °C, ramp to
135 °C with a rate of 3 °C min−1, ramp to 240 °C with a rate of 20 °C min−1, and hold
for 5min. To detect terpenols derived by the acid treatment of prenyl diphosphates,
the temperature program of GC–MS analysis was modiﬁed as follows: initial tem-
perature 60 °C, hold for 3 min, ramp to 80 °C with a rate of 3 °C min−1, ramp to
110 °C with a rate of 30 °C min−1, ramp to 130 °C with a rate of 3 °C min−1, ramp to
280 °C with a rate of 30 °C min−1 and hold for 3 min.
GC-FID analysis. GC-FID was carried on a HP-5MS UI capillary column (Agilent
Technologies) with a (5%-Phenyl)-methylpolysiloxane (Ultra Inert) stationary
phase. Column dimensions were 30 m length × 0.25 mm internal diameter × 0.25
ﬁlm thickness. Helium was used as a carrier gas with a constant velocity of 50 cm/s.
The instrument was equipped with a PTV injector. Hexane samples were analyzed
using the following temperature program: hold initial temperature at 40 °C for
3 min, ramp to 80 °C with a rate of 3 °C min−1, followed by a ramp to 300 °C with a
rate of 30 °C min−1, and a hold for 10 min.
GC–APCI–QqToF analysis. GC–APCI–QqToF analyses were performed using a
Scion 456 GC system (Bruker Daltonics) coupled to a micrOTOF-Q II (QqToF)
mass spectrometer (Bruker Daltonics) via an atmospheric pressure chemical
ionization (APCI) source. Samples were analyzed by injecting 1 µL aliquots in
splitless injection mode (injector temperature 250 °C) onto a BR-5ms capillary
column (30 m × 0.25 mm ID × 0.25 µm ﬁlm thickness; Bruker Daltonics). The
samples were eluted using helium as the carrier gas with a constant ﬂow of 1.0 mL
min−1. The temperature gradient of the GC oven was programmed as follows:
initial temperature 50 °C was held for 1 min, before a ramp to 280 °C at a rate of
15 °C min−1, and subsequent hold for 3.67 min, giving a total method duration of
20 min. The transfer line between the GC and QqToF was maintained at 280 °C
throughout the analysis. The head temperature of the APCI source was set to
280 °C, and the APCI heater to 200 °C, with a charging voltage of 2000 V. The
QqToF mass spectrometer was operated in full scan positive ion mode with the
following instrument settings: m/z 80–310: nebulizer gas (nitrogen), 3.5 bar; drying
gas (nitrogen), 2.5 L min−1; drying gas temperature, 240 °C; capillary voltage,
3000 V; spectra acquisition rate, 5 Hz. Every chromatogram was calibrated for
accurate mass using automated infusion of perﬂuorotributylamine vapor (PFTBA;
Sigma-Aldrich) for a short period at the beginning of each chromatographic run.
All data acquisition was automated using a combination of Compass CDS (Version
3.0.1; Bruker Daltonics), Compass oTOF Control (Version 3.4, Bruker Daltonics)
and Hystar (Version 3.2 SR4, Bruker Daltonics) software. For data analysis,
Compass DataAnalysis software (Version 4.3, Bruker Daltonics) was used.
Calculation of labeled:unlabeled limonene ratio. The relative contribution of
GPP and NPP to limonene synthesis was estimated in competition assays where
either GPP or NPP was labeled with two 13C, causing a +2 mass shift in the
proportion of the limonene mass spectra stemming from the labeled substrate. The
limonene mass spectra contained a large amount of −2H ions for each major ion,
causing the 13C-labeled limonene to have signiﬁcant overlap with the major ions of
unlabeled limonene. The ratio between unlabeled and labeled limonene could,
therefore, not be accurately calculated directly from the + 2 shift in major mass
ions. It was instead estimated by comparing four ion pairs of unlabeled −2H and
labeled +213C of m/z 135/139, 166/170, 191/195 and 205/209. The ratios for each
pair were calculated based on the known relative ratio between signal intensities of
each ion pair in the mass spectra between pure unlabeled and labeled limonene at
equal concentrations. The weighted average and standard errors were calculated
using the signal to noise for each pair as weighting. Details with exact numbers and
calculations are provided in the Data Source ﬁle (sheets named Supplementary
Fig. 12a and Supplementary Fig. 12b).
Molecular graphics. Molecular graphics were produced using the UCSF Chimera
package. Chimera is developed by the Resource for Biocomputing, Visualization,
and Informatics at the University of California, San Francisco (supported by
NIGMS P41-GM103311)68.
Compound identiﬁcation. Identiﬁcation of monoterpene compounds produced by
yeast cells was based on GC–MS analysis and comparison of retention times and
mass spectra with authentic standards (listed earlier in this section under Che-
micals and enzymes).
Mutagenesis. Site-directed mutagenesis using the Quickchange method (Agilent)
was performed for SfCinS1, SpSabS, and SelCamS, while USER mutagenesis69 was
performed for PtPinS and ClLimS. The primers used for mutagenesis purposes are
listed in Supplementary Table 7.
Construction of the SfCinS model. A structural model of SfCinS1 was constructed
using the SWISS-MODEL server70 using mint limonene synthase (pdb id: 2ong) as
template. The 2-ﬂuorolinalyl diphosphate and 2-ﬂuorogeranyl diphosphate ligands
were then superimposed on the model, based on their position in the mint limo-
nene synthase structure.
General chemical synthesis procedures. All reactions were monitored by TLC
on aluminum sheets coated with silica gel 60F254 (0.2-mm thickness, Merck) and
the components present were detected by charring with 10% H2SO4 in MeOH.
Column chromatography was carried out using silica gel 60 (particle size
0.040–0.063 mm, 230–400 mesh ASTM, Merck). Solvent extracts were dried with
anhydrous MgSO4 unless otherwise speciﬁed. The 1H and 13C NMR spectra were
recorded on a Bruker Avance 400 spectrometer at 400 and 101MHz, respectively.
CDCl3 was used as solvent (unless otherwise indicated), δH values are relative to
internal TMS and δC values are referenced to the solvent [δC (CDCl3)= 77.0].
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Synthesis of 13C-labeled neryl- and GPP. Chemical synthesis of (Z)-[1,2-13C2]-
neryl pyrophosphate 5a and its isomer (E)-[1,2- 13C2]-geranyl pyrophosphate 5b
was performed according to the following procedure:
To synthesize ethyl (Z)-[1,2-13C2]-3,7-dimethylocta-2,6-dienoate (3a) and ethyl
(E)-[1,2-13C2]-3,7-dimethylocta-2,6-dienoate (3b), a neat mixture of LiCl (0.25 g,
5.9 mmol), triethyl phosphono-13C2-acetate (1) (1.0 g, 4.4 mmol) and DBU (1,8-
diazabicyclo[5,4,0]undec-7-ene) (0.72 mL, 4.9 mmol) was stirred at rt for 1.0 h
under Ar followed by the addition of 6-methyl-5-hepten-2-one (2) (2.3 mL,
15.6 mmol). Stirring was continued at rt for 24 h. The reaction was quenched with
water (50 mL) and the reaction mixture was extracted with Et2O (200 mL). The
extract was washed with brine and dried (MgSO4). The solvent was evaporated and
chromatographed on silica (100 g) with 0–10% Et2O in n-pentane to afford the
separation of the pure (Z)-isomer 3a as colorless oil (87.0 mg, 10%), E/Z-mixture
(560.0 mg, 68%) and pure (E)-isomer 3b (175.0 mg, 20%) (829.0 mg in total, 95%).
To synthesize (Z)-[1,2-13C2]-3,7-dimethylocta-2,6-diene-1-ol (4a), a stirred
solution of ethyl (Z)-[1,2- 13C2]-3,7-dimethylocta-2,6-dienoate (3a) (60.0 mg,
0.30 mmol) in diethyl ether (5.0 mL) and cooled to −78 °C. DIBAL-H (1.0 M in
toluene) (0.73 mL, 0.73 mmol) was added dropwise and the reaction mixture was
stirred at −78 °C for 1 h and then quenched by addition of MeOH (0.5 mL). The
reaction mixture was warmed gradually to 0 °C and diluted with Et2O (10 mL)
followed by the addition of saturated aqueous solution of Rochelle salt (10 mL),
water (10 mL) and vigorously stirred. Once the Et2O layer became clear, it was
separated, dried over MgSO4, ﬁltered, and concentrated on a rotary evaporator
under reduced pressure. Chromatographic puriﬁcation of the resulting oil on silica
(14 g) with 20% Et2O in n-pentane afforded the separation of the pure 4a colorless
oil (45.0 mg, colorless oil, 96%).
(E)-[1,2-13C2]-3,7-dimethylocta-2,6-diene-1-ol (4b) was synthesized exactly as
described for the alcohol 4a.
The structure of (Z)- [1,2-13C2]-3,7-Dimethylocta-2,6-diene-1-ol (4a) was
conﬁrmed by NMR and HRMS analysis. 1H NMR (600MHz, CDCl3): δ1.61 (s, 3H),
1.69 (d, 4JH,H= 0.9 Hz,3H), 1.75 (dd, 3JCH3,C-1= 6.0 Hz, 4JH,H= 0.9 Hz, 3H), 2.10
(m, 4H,–CH2CH2–), 3.42 (d, 2JOH,C-1= 6.5 Hz,1H, OH), 4.09 (dddd, 1JH-1,C-1 =
141.9 Hz, 2JH-1,H-1= 12.3 Hz, 3JH-1,H-2= 7.2 Hz, 2JH-1,C-2= 4.0 Hz, 4J H-1,H-4= 0.8
Hz, 2H, –13CH2–OH), 5.10 (m, 1H, H-6), 5.45 (dtm, 1JH-2,C-2= 152.4 Hz, 3J= 7.2
Hz, 1H); 13C NMR (151MHz, CDCl3): δ 59.2 (d, 1JC–C= 47.5 Hz, 13C-1), 124.4 (d,
1JC–C= 47.5 Hz, 13C-−2), (only peaks for 13C-labeled carbons reported). HRMS
(m/z): [M+H–H20]+ calcd. For 13C2C8H18O, 139.1397; found, 139.1392.
The structure of (E)-[1,2-13C2]-3,7-Dimethylocta-2,6-diene-1-ol (4b) was
conﬁrmed by NMR and HRMS analysis. H NMR (600 MHz, CDCl3): δ1.61 (s,
3H), 1.68 (s, 3H), 1.75 (s, 3H), 2.03 and 2.11 (2m, 4H,–CH2CH2–), 3.41 (d, 2JOH,
C−1= 6.5 Hz,1H, OH), 4.16 (dddd, 1JH-1,C-1= 141.8 Hz, 2JH-1,H-1= 11.5 Hz, 3JH-
1,H-2= 7.0 Hz, 2JH-1,C-2= 4.0 Hz, 4J H-1,H-4= 0.6 Hz, 2 H, –13CH2–OH), 5.10 (tm,
J= 7.0 Hz,1H, H−6), 5.45 (dtm, 1JH−2,C−2= 152.4 Hz, 3J= 7.0 Hz, 1H). 13C
NMR (151 MHz, CDCl3): δ59.6 (d, 1JC–C= 47.5 Hz, 13C-1), 124.4 (d, 1JC–C=
47.5 Hz, 13C-2), (only peaks for 13C-labeled carbons reported). HRMS (m/z):
[M+H–H20]+ calcd. For 13C2C8H18O, 139.1397; found, 139.1387.
To synthesize (Z)-[1,2-13C2]-neryl pyrophosphate (5a), a stirred solution of (Z)-
[1,2-13C2]-3,7-dimethylocta-2,6-diene-1-ol (4a) (15.6mg, 0.10mmol) in dry benzene
(2.0mL) and dry CH2Cl2 (0.2mL) was added CBr4 (68.0 mg, 0.21mmol) and Ph3P
(54.0mg, 0.21mmol) at 0 °C under a nitrogen atmosphere. After the solution was
stirred at the same temperature for 2 h, n-pentane (2.0mL) was added to the reaction
mixture. The reaction mixture was ﬁltered to remove triphenylphosphine oxide. The
ﬁltrate was concentrated under reduced pressure to afford the crude (Z)-neranyl
bromide (22.0mg, quant.) as yellow oil which was immediately subjected to the
following pyrophosphorylation reaction without further puriﬁcation. A solution of the
crude bromide in dry CH3CN (2mL) was added dropwise to a stirred solution of [(n-
Bu4)N]3HP2O7 (135.0mg, 0.15mmol, 1.5 eq) in dry CH3CN (2.0mL) at 0 °C under
Ar. The mixture was stirred at rt for 24 h and concentrated on a rotary evaporator
below 35 °C. The obtained residue was transferred to a centrifuge tube with 5.0mL of
acetone and concentrated NH4OH (0.5–1mL) was added. The precipitated
ammonium salts, isolated by centrifugation (1500 × g for 10min), washed twice by
resuspension in 5.0 of acetone containing 0.01 N NH4OH. The combined
supernatants of the acetone containing NH4OH were roto-evaporate at below 35 °C.
The resulting crude (Z)-[1,2-13C2]-neryl pyrophosphate 5a as its ammonium salt was
pure enough to be used for the enzymatic studies. However, a pure sample of 5a was
accomplished by preparative TLC-plates using the eluent system MeOH/CH2Cl2/0.01
N NH4OH (1: 1.2: 0.3 v/v).
(E)-[1,2-13C2]-geranyl pyrophosphate 5b was synthesized exactly as described
for 5a. When synthesized organic pyrophosphates 5a and 5b were subjected to acid
hydrolysis, the recovered alcohol was compared with authentic samples by TLC
and GC–HRMS. In each case, the recovered alcohol was essentially identical with
the corresponding alcohols 4a and 4b, respectively.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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Supplementary Information ﬁles. A reporting summary for this article is available as a
Supplementary Information ﬁle. The data sets generated and analyzed during this study are
available from the corresponding author upon request. The source data underlying
Tables 1–3; Figs. 2c, d, 3a–e, 4a, 5a–d, g; Supplementary Tables 2–6, and 8; Supplementary
Figs. 1, 2, 3a, b, 4a, b, 6, 7, 8a, b, 10a, b, 12a, b are provided as a Source Data ﬁle.
Received: 23 September 2018 Accepted: 3 July 2019
References
1. Liu, C. C., Jewett, M. C., Chin, J. W. & Voigt, C. A. Toward an orthogonal
central dogma. Nat. Chem. Biol. 14, 103–106 (2018).
2. de Lorenzo, V. Beware of metaphors: chasses and orthogonality in synthetic
biology. Bioeng. Bugs 2, 3–7 (2011).
3. Pandit, A. V., Srinivasan, S. & Mahadevan, R. Redesigning metabolism based
on orthogonality principles. Nat. Commun. 8, 15188 (2017).
4. Tan, S. Z. & Prather, K. L. Dynamic pathway regulation: recent advances and
methods of construction. Curr. Opin. Chem. Biol. 41, 28–35 (2017).
5. Dahl, R. H. et al. Engineering dynamic pathway regulation using stress-
response promoters. Nat. Biotechnol. 31, 1039–1046 (2013).
6. Gupta, A., Reizman, I. M., Reisch, C. R. & Prather, K. L. Dynamic regulation
of metabolic ﬂux in engineered bacteria using a pathway-independent
quorum-sensing circuit. Nat. Biotechnol. 35, 273–279 (2017).
7. Xu, P., Li, L., Zhang, F., Stephanopoulos, G. & Koffas, M. Improving fatty
acids production by engineering dynamic pathway regulation and metabolic
control. Proc. Natl Acad. Sci. USA 111, 11299–11304 (2014).
8. Doong, S. J., Gupta, A. & Prather, K. L. J. Layered dynamic regulation for
improving metabolic pathway productivity in Escherichia coli. Proc. Natl
Acad. Sci. USA 115, 2964–2969 (2018).
9. Venayak, N., von Kamp, A., Klamt, S. & Mahadevan, R. MoVE identiﬁes
metabolic valves to switch between phenotypic states. Nat. Commun. 9, 5332
(2018).
10. Vickers, C. E., Williams, T. C., Peng, B. & Cherry, J. Recent advances in
synthetic biology for engineering isoprenoid production in yeast. Curr. Opin.
Chem. Biol. 40, 47–56 (2017).
11. Zebec, Z. et al. Towards synthesis of monoterpenes and derivatives using
synthetic biology. Curr. Opin. Chem. Biol. 34, 37–43 (2016).
12. George, K. W., Alonso-Gutierrez, J., Keasling, J. D. & Lee, T. S. Isoprenoid
drugs, biofuels, and chemicals–artemisinin, farnesene, and beyond. Adv.
Biochem. Eng. Biotechnol. 148, 355–389 (2015).
13. Jongedijk, E. et al. Biotechnological production of limonene in
microorganisms. Appl. Microbiol. Biotechnol. 100, 2927–2938 (2016).
14. Ignea, C., Pontini, M., Maffei, M. E., Makris, A. M. & Kampranis, S. C.
Engineering monoterpene production in yeast using a synthetic dominant
negative geranyl diphosphate synthase. ACS Synth. Biol. 3, 298–306 (2014).
15. Alonso-Gutierrez, J. et al. Metabolic engineering of Escherichia coli for
limonene and perillyl alcohol production. Metab. Eng. 19, 33–41 (2013).
16. Zhang, L. et al. Chassis and key enzymes engineering for monoterpenes
production. Biotechnol. Adv. 35, 1022–1031 (2017).
17. Sarria, S., Wong, B., Garcia Martin, H., Keasling, J. D. & Peralta-Yahya, P.
Microbial synthesis of pinene. ACS Synth. Biol. 3, 466–475 (2014).
18. Croteau, R. Biosynthesis and catabolism of monoterpenoids. Chem. Rev. 87,
929–954 (1987).
19. Ro, D. K. et al. Production of the antimalarial drug precursor artemisinic acid
in engineered yeast. Nature 440, 940–943 (2006).
20. Westfall, P. J. et al. Production of amorphadiene in yeast, and its conversion to
dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc.
Natl Acad. Sci. USA 109, E111–E118 (2012).
21. Paddon, C. J. et al. High-level semi-synthetic production of the potent
antimalarial artemisinin. Nature 496, 528–532 (2013).
22. Meadows, A. L. et al. Rewriting yeast central carbon metabolism for industrial
isoprenoid production. Nature 537, 694–697 (2016).
23. Peng, B., Nielsen, L. K., Kampranis, S. C. & Vickers, C. E. Engineered protein
degradation of farnesyl pyrophosphate synthase is an effective regulatory
mechanism to increase monoterpene production in Saccharomyces cerevisiae.
Metab. Eng. 47, 83–93 (2018).
24. Peng, B. et al. A squalene synthase protein degradation method for improved
sesquiterpene production in Saccharomyces cerevisiae. Metab. Eng. 39,
209–219 (2017).
25. Anderson, M. S., Yarger, J. G., Burck, C. L. & Poulter, C. D. Farnesyl
diphosphate synthetase. Molecular cloning, sequence, and expression of an
essential gene from Saccharomyces cerevisiae. J. Biol. Chem. 264, 19176–19184
(1989).
26. Liebermeister, W. Enzyme economy in metabolic networks. Preprint at
https://arXiv:1404.5252 [q-bio.MN] (2014).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11290-x ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3799 | https://doi.org/10.1038/s41467-019-11290-x | www.nature.com/naturecommunications 13
27. Ignea, C. et al. Positive genetic interactors of HMG2 identify a new set of
genetic perturbations for improving sesquiterpene production in
Saccharomyces cerevisiae. Microb. Cell Factories 11, 162 (2012).
28. Schilmiller, A. L. et al. Monoterpenes in the glandular trichomes of tomato are
synthesized from a neryl diphosphate precursor rather than geranyl
diphosphate. Proc. Natl Acad. Sci. USA 106, 10865–10870 (2009).
29. Sallaud, C. et al. A novel pathway for sesquiterpene biosynthesis from Z,Z-
farnesyl pyrophosphate in the wild tomato Solanum habrochaites. Plant Cell
21, 301–317 (2009).
30. Gonzales-Vigil, E., Hufnagel, D. E., Kim, J., Last, R. L. & Barry, C. S. Evolution
of TPS20-related terpene synthases inﬂuences chemical diversity in the
glandular trichomes of the wild tomato relative Solanum habrochaites. Plant J.
71, 921–935 (2012).
31. Denby, C. M. et al. Industrial brewing yeast engineered for the production of
primary ﬂavor determinants in hopped beer. Nat. Commun. 9, 965 (2018).
32. Brennan, T. C., Turner, C. D., Kromer, J. O. & Nielsen, L. K. Alleviating
monoterpene toxicity using a two-phase extractive fermentation for the
bioproduction of jet fuel mixtures in Saccharomyces cerevisiae. Biotechnol.
Bioeng. 109, 2513–2522 (2012).
33. Lucker, J. et al. Monoterpene biosynthesis in lemon (Citrus limon). cDNA
isolation and functional analysis of four monoterpene synthases. Eur.
J. Biochem. 269, 3160–3171 (2002).
34. Faulkner, A. et al. The LPP1 and DPP1 gene products account for most of the
isoprenoid phosphate phosphatase activities in Saccharomyces cerevisiae. J.
Biol. Chem. 274, 14831–14837 (1999).
35. Stanley Fernandez, S. M., Kellogg, B. A. & Poulter, C. D. Farnesyl diphosphate
synthase. Altering the catalytic site to select for geranyl diphosphate activity.
Biochemistry 39, 15316–15321 (2000).
36. Springer, M., Weissman, J. S. & Kirschner, M. W. A general lack of
compensation for gene dosage in yeast. Mol. Syst. Biol. 6, 368 (2010).
37. Ignea, C. et al. Efﬁcient diterpene production in yeast by engineering Erg20p
into a geranylgeranyl diphosphate synthase. Metab. Eng. 27, 65–75
(2015).
38. Ignea, C. et al. Overcoming the plasticity of plant specialized metabolism for
selective diterpene production in yeast. Sci. Rep. 7, 8855 (2017).
39. Ignea, C. et al. Synthesis of 11-carbon terpenoids in yeast using protein and
metabolic engineering. Nat. Chem. Biol. 14, 1090–1098 (2018).
40. Zhang, M., Liu, J., Li, K. & Yu, D. Identiﬁcation and characterization of a
novel monoterpene synthase from soybean restricted to neryl diphosphate
precursor. PloS One 8, e75972 (2013).
41. Kampranis, S. C. et al. Rational conversion of substrate and product speciﬁcity
in a salvia monoterpene synthase: structural insights into the evolution of
terpene synthase function. Plant Cell 19, 1994–2005 (2007).
42. Phillips, M. A., Wildung, M. R., Williams, D. C., Hyatt, D. C. & Croteau, R.
cDNA isolation, functional expression, and characterization of (+)-alpha-
pinene synthase and (-)-alpha-pinene synthase from loblolly pine (Pinus
taeda): stereocontrol in pinene biosynthesis. Arch. Biochem. Biophys. 411,
267–276 (2003).
43. Tsaballa, A. et al. Use of the de novo transcriptome analysis of silver-leaf
nightshade (Solanum elaeagnifolium) to identify gene expression changes
associated with wounding and terpene biosynthesis. BMC Genom. 16, 504
(2015).
44. Hyatt, D. C. et al. Structure of limonene synthase, a simple model for
terpenoid cyclase catalysis. Proc. Natl Acad. Sci. USA 104, 5360–5365
(2007).
45. Gesell, A. et al. The gymnosperm cytochrome P450 CYP750B1 catalyzes
stereospeciﬁc monoterpene hydroxylation of (+)-sabinene in thujone
biosynthesis in western redcedar. Plant Physiol. 168, 94–106 (2015).
46. Ro, D. K., Ehlting, J. & Douglas, C. J. Cloning, functional expression, and
subcellular localization of multiple NADPH-cytochrome P450 reductases
from hybrid poplar. Plant Physiol. 130, 1837–1851 (2002).
47. Leber, R. et al. A novel sequence element is involved in the transcriptional
regulation of expression of the ERG1 (squalene epoxidase) gene in
Saccharomyces cerevisiae. Eur. J. Biochem. 268, 914–924 (2001).
48. Yuan, J. & Ching, C. B. Dynamic control of ERG9 expression for improved
amorpha-4,11-diene production in Saccharomyces cerevisiae. Microb. Cell
Factories14, 38 (2015).
49. Callari, R., Meier, Y., Ravasio, D. & Heider, H. Dynamic control of ERG20 and
ERG9 expression for improved casbene production in Saccharomyces
cerevisiae. Front. Bioeng. Biotechnol. 6, 160 (2018).
50. Erb, T. J., Jones, P. R. & Bar-Even, A. Synthetic metabolism: metabolic
engineering meets enzyme design. Curr. Opin. Biotechnol. 37, 56–62
(2017).
51. Lynch, M. D. Into new territory: improved microbial synthesis through
engineering of the essential metabolic network. Curr. Opin. Biotechnol. 38,
106–111 (2016).
52. Alonso-Gutierrez, J. et al. Principal component analysis of proteomics (PCAP)
as a tool to direct metabolic engineering. Metab. Eng. 28, 123–133 (2015).
53. Mendez-Perez, D. et al. Production of jet fuel precursor monoterpenoids from
engineered Escherichia coli. Biotechnol. Bioeng. 114, 1703–1712 (2017).
54. Zhang, H. et al. Microbial production of sabinene-a new terpene-based
precursor of advanced biofuel. Microb. Cell Factories 13, 20 (2014).
55. Paddon, C. J. & Keasling, J. D. Semi-synthetic artemisinin: a model for the use
of synthetic biology in pharmaceutical development. Nat. Rev. Microbiol. 12,
355–367 (2014).
56. Tashiro, M. et al. Bacterial production of pinene by a laboratory-evolved
pinene-synthase. ACS Synth. Biol. 5, 1011–1020 (2016).
57. Bakkali, F., Averbeck, S., Averbeck, D. & Idaomar, M. Biological effects of
essential oils-a review. Food Chem. Toxicol. 46, 446–475 (2008).
58. Dunlop, M. J. et al. Engineering microbial biofuel tolerance and export using
efﬂux pumps. Mol. Syst. Biol. 7, 487 (2011).
59. Todorovic, B. et al. Toxicity of twenty-two plant essential oils against
pathogenic bacteria of vegetables and mushrooms. J. Environ. Sci. Health B.
51, 832–839 (2016).
60. George, K. W. et al. Integrated analysis of isopentenyl pyrophosphate (IPP)
toxicity in isoprenoid-producing Escherichia coli. Metab. Eng. 47, 60–72
(2018).
61. Zi, J. et al. Biosynthesis of lycosantalonol, a cis-prenyl derived diterpenoid. J.
Am. Chem. Soc. 136, 16951–16953 (2014).
62. Matsuba, Y., Zi, J., Jones, A. D., Peters, R. J. & Pichersky, E. Biosynthesis of the
diterpenoid lycosantalonol via nerylneryl diphosphate in Solanum
lycopersicum. PloS ONE 10, e0119302 (2015).
63. Jia, Q. et al. Microbial-type terpene synthase genes occur widely in nonseed
land plants, but not in seed plants. Proc. Natl Acad. Sci. USA 113,
12328–12333 (2016).
64. Behrendorff, J. B., Vickers, C. E., Chrysanthopoulos, P. & Nielsen, L. K. 2,2-
diphenyl-1-picrylhydrazyl as a screening tool for recombinant monoterpene
biosynthesis. Microb. Cell Fact. 12, 76 (2013).
65. Ignea, C. et al. Improving yeast strains using recyclable integration cassettes,
for the production of plant terpenoids. Microb. Cell Factories 10, 4
(2011).
66. Trikka, F. A. et al. Combined metabolome and transcriptome proﬁling
provides new insights into diterpene biosynthesis in S. pomifera glandular
trichomes. BMC Genom. 16, 935 (2015).
67. Ignea, C. et al. Production of the forskolin precursor 11beta-hydroxy-manoyl
oxide in yeast using surrogate enzymatic activities. Microb. Cell Factories 15,
46 (2016).
68. Pettersen, E. F. et al. UCSF Chimera–a visualization system for exploratory
research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
69. Genee, H. J. et al. Software-supported USER cloning strategies for site-directed
mutagenesis and DNA assembly. ACS Synth. Biol. 4, 342–349 (2015).
70. Peitsch, M. C. ProMod and Swiss-Model: Internet-based tools for automated
comparative protein modelling. Biochem. Soc. Trans. 24, 274–279 (1996).
Acknowledgements
We thank Dr Violetta Aru (Chemometrics & Analytical Technology, Department of
Food Science, University of Copenhagen, Denmark) for performing the NMR experi-
ments, Dr David Ian Pattison (Metabolomics Platform, Department of Plant and
Environmental Sciences, University of Copenhagen, Denmark) for technical support in
metabolite analysis and description of the GC–APCI–QqToF parameters and method,
Eleni Lazaridi and Stephanie Petersen for technical assistance with the GC instruments
(Metabolomics Platform, Department of Plant and Environmental Sciences, University of
Copenhagen, Denmark), and Karel Miettinen (University of Copenhagen, Denmark) for
critical reading of the manuscript. This work was supported by the Novo Nordisk
Foundation (grants NNF16OC0019554 to C.I. and NNF16OC0021760 to S.C.K.) and the
General Secretariat of Science and Technology Hellas (GSRT; grant SysTerp 09ΣΥΝ-23-
879 to AMM and S.C.K.). C.E.V. was supported by a Queensland Government Accelerate
Fellowship.
Author contributions
C.I. designed experiments, expressed and analyzed SlNPPS1 and monoterpene synthases
in yeast and bacteria, performed mutagenesis of SfCinS1, PtPinS, SpSabS, ClLimS,
SeCamS, produced the integration cassette for PERG1 and generated the MIC3-derived
strains, performed the enzymatic assays for precursor ﬂux analysis and competition
experiments, analyzed the yeast growth parameters for toxicity experiments, analyzed the
data, and drafted the paper; M.H.R. performed mutagenesis experiments, quantiﬁed
limonene and sabinene production in yeast under shake-ﬂask batch and semi-batch
cultivation conditions and carried out toxicity and productivity evaluations, conducted
the GC–qTOF analysis and contributed to the cloning of PERG1 and the construction of
the dynamically controlled MIC3 strain; M.S.M. performed the chemical synthesis of
13C-GPP and 13C-NPP. A.M.M. prepared the SlNPPS1 expression construct and parti-
cipated in data analysis; C.E.V. provided essential reagents and assisted in data inter-
pretation and paper revision; S.C.K. conceived the project, designed experiments,
analyzed the data, and drafted the paper.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11290-x
14 NATURE COMMUNICATIONS |         (2019) 10:3799 | https://doi.org/10.1038/s41467-019-11290-x | www.nature.com/naturecommunications
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
019-11290-x.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Peer review information: Nature Communications thanks Radhakrishnan Mahadevan,
Annie Tsong and the other, anonymous, reviewer(s) for their contribution to the peer
review of this work. Peer reviewer reports are available.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11290-x ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3799 | https://doi.org/10.1038/s41467-019-11290-x | www.nature.com/naturecommunications 15
